Skip to main content
PolicySpeak
← All files
LP

Laboratoire PAREVA

Company · France

2
positions filed
in the 326 files tracked
1
legislative file
of 326 tracked
0
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Track Laboratoire in PolicySpeak: request access →

Work at Laboratoire PAREVA? so we know who speaks for it.

Follow the file Laboratoire PAREVA engages with

One email on Tuesdays when a new position is filed on this file, from Laboratoire PAREVA or from anyone else on it. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Laboratoire PAREVA filed 2 positions on 5 Mar 2026, across 1 of the 326 legislative files tracked here.

What they argued

Evaluation of the Biocidal Products Regulationfiled 5 Mar 2026source

The following points should be discussed to simplify the BPR, while aiming to reduce the growing ‎inequality between active substancesa result of delays in the Review Program and the introduction ‎of new regulatory requirements:‎ ‎(1)‎ Require MSCA to prioritize the assessment of Active Substance (AS) dossiers that have never ‎been evaluated.

Evaluation of the Biocidal Products Regulationfiled 5 Mar 2026source

Our proposal to simplify the BPR: ‎ ‎ – ‎ A single dossier only per biocidal Active Substance, ‎ regardless of the number of intended product ‎ types (pts) to be supported ‎ – Composition of such dossier: Only Part A is required (meeting the requirements of Annex II of the ‎ BPR). ‎ – Uniform application: The same rule applies to both new active substances and existing ones (under ‎ the Review Programme).

Filed in French · English published by the European Commission

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Is this your organization?

Everything on this page comes from Laboratoire PAREVA’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.